November 2016 Volume 12, Issue 11
Volume 12, Issue 11 | November 2016
November 2016
In this Issue
Business & Government Policy
Patent Docs: Scope of Hatch-Waxman ‘safe harbor’ remains unclear
The question of whether activities undertaken post-approval are subject to the act has not been subject to Supreme Court review and recently it declined such review in a specific caseNext- generation cancer partnership
Investigational therapy uses an oncolytic virus platform to infect and break down cancerOff the shelf and into the lab
Fate Therapeutics and Memorial Sloan Kettering to develop off-the-shelf T cell product candidatesOn the cutting edge
A roundup of instrumentation, software and other tools and technology newsDiscovery
Tarveda licenses HSP90 drug conjugate platform
Deal with Madrigal Pharmaceuticals could be worth in excess of $249 millionThe eyes have it
Indiana U. wins $1.9M NIH grant for blindness prevention through research on photoreceptorsCompanies join forces to improve R&D
drug discovery, drug development, R&DA new partnership ‘Blooms’ for 3D models
Plasticell and CellSpring collaborate on tissue models for drug candidate screeningU.K. drug discovery landscape in fundamental shift
According to a new report, the British drug arena is headed more toward collaboration and open innovationClinical Trials
Managing migraine
Drug treats migraine symptoms without cardiovascular riskGoing after Crohn’s and colitis
Celgene announces positive data from two studies of oral therapies for the gastrointestinal conditionsRomosozumab impresses in osteoporosis trial
FRAME study demonstrates effectiveness of drug that binds and inhibits activity of sclerostinA Phase 1, 2 punch to Parkinson’s disease
Phase 1 clinical trial shows PXT002331 to be a potential weapon against Parkinson’s diseaseAn ACTIVE accomplishment
Radius’ abaloparatide-SC reduces fractures, boosts bone mineral density in postmenopausal women with osteoporosisEditor's Focus
An update on Cancer Moonshot efforts
The Cancer Moonshot program launched in January by President Barack Obama is something we've been covering here and there in DDNews, and now we catch you up on some of the latest activitiesCommentary
Out of order: Being human
There is certainly value to finding ways to alleviate some of the most challenging and debilitating aspects of autism, but DDNews Features Editor Randall C Willis offers a suggestion: Maybe we shouldn't be trying to actually 'cure' autism per seGuest Commentary: Accelerating discovery through contract chemical synthesis
Contract chemistry laboratories are playing an increasingly important role in pharma R&D, and Jeremiah Malerich and colleagues from SRI International share their insights about the role contract chemistry plays in drug discoveryFeature
ASCB 2016 Show Preview: Following the arc of scientific discovery
American Society for Cell Biology 56th annual meeting headed for San FranciscoResearch & Development
‘A one-step, one-flask process’
Scientists stumble upon revolutionary process in drug design and synthesisHeadway on HIV
TSRI identifies Env ‘holes’ and bnAbs as potential new approaches in targeting HIVA duo for single-cell sequencing
TTP Labtech/UC San Diego collaboration accelerates single-cell genomics researchPair of grants for a protein program
Inventiva nets €2.3 million to pursue YAP/TEAD researchPreclinical
A new option for Sanfilippo?
Abeona’s preclinical data support gene therapy for rare disorder MPS IIIAVaxonella vs. Zika
Prokarium seeks to develop world’s first oral vaccine against Zika virusA new cancer combination
AsiDNA and PARP inhibitors demonstrate synergistic effect, bypass genetic restrictionIt’s all in the presentation
A quick roundup of some recent preclinical data presentationsDiagnostics
Putting cancer breath test through the paces
Owlstone Medical embarks on world’s largest clinical trial for breath-based lung cancer detectionBone breakthrough
Austrian company demonstrates miRNA-based test for early detection of osteoporosisCancer Genetics and BARC launch partnership
Initial focus will be on immuno-oncology, hematological cancers and lung cancerMeeting up for MDx
New Agilent/Burning Rock deal to focus on cancer diagnosticsContract Services
Bracket gets random with integrated PBD technology
Clinical trial tech and services company becomes first clinical IRT provider to natively integrate PBDPAREXEL acquires ExecuPharm to broaden functional service depth
Deal is part of ongoing effort to serve a broader customer base of varying sizes with varying abilitiesIdeathon makes an ‘Inspiring’ first showing
The ‘Inspiring Hope’ Ideathon crowdsources ideas for boosting clinical trial awareness and participationExco InTouch boasts quadrupled growth
September saw Exco InTouch celebrate its recognition on the Sunday Times Hiscox Tech Track 100
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
